Moringa oleifera Nanoparticles Modulate Genes Expression Involved in Doxorubicin-Induced Cardiotoxicity in Rats | ||
| Suez Canal Veterinary Medical Journal. SCVMJ | ||
| Volume 30, Issue 2, December 2025, Pages 363-380 | ||
| Document Type: Original Article | ||
| DOI: 10.21608/scvmj.2025.433533.1218 | ||
| Authors | ||
| Rehab A.M. Gouda* 1; Abeer G. Ali Hassan2; Yasmina K. Mahmoud2; Abrahim A Ibrahim2 | ||
| 1Free Veterinarian | ||
| 2Department of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt. | ||
| Abstract | ||
| Introduction: Nano-formulations of Moringa oleifera have various medicinal interests. It has been used to combat the consequences of many chemotherapeutics. Aim: The study was conducted to assess the molecular effect of Moringa oleifera nanoparticles (MONPs) on doxorubicin-induced cardiotoxicity (DIC) in breast cancer-induced rats (BC-induced). Material and methods: 35 albino rats were categorized into control (healthy) and BC-induced rats. The BC-induced group was further categorized into 4 groups to assess both prophylactic and synergistic action of MONPs. mRNA was extracted from cardiac tissues, then cDNA was synthesized, and primers for Smad3, 7, TGF- , STAT3, and Let-7b were used for amplification by RT-PCR. Results: MONPs induced a significant reduction in the mRNA expression levels of TGF-β1/Smad3, JAK-1/STAT3 pathways genes, and a significant elevation in the mRNA expression levels of Smad7 and miRNA Let-7b. Conclusion: Findings of the present study approved the powerful potential of MONPs to mitigate DIC in BC-induced rats, opening the way for their use as a supportive and protective agent during the use of DOX as chemotherapy | ||
| Keywords | ||
| Cardiotoxicity; Doxorubicin; Moringa | ||
|
Statistics Article View: 36 |
||
